Transcutaneous neuromodulation device

Chu , et al. June 15, 2

Patent Grant D922593

U.S. patent number D922,593 [Application Number D/693,185] was granted by the patent office on 2021-06-15 for transcutaneous neuromodulation device. This patent grant is currently assigned to Apex Neuro Holdings, Inc.. The grantee listed for this patent is Apex Neuro Inc.. Invention is credited to Geoff Baldwin, Zen Chu, Sean Hagberg, Thomas Kershaw, Francois Kress, Jainam Shah, Priyanka Venkatesh, Christopher Wright.


United States Patent D922,593
Chu ,   et al. June 15, 2021

Transcutaneous neuromodulation device

Claims

CLAIM The ornamental design for a transcutaneous neuromodulation device, substantially as shown and described.
Inventors: Chu; Zen (Brookline, MA), Hagberg; Sean (Cranston, RI), Kress; Francois (New York, NY), Shah; Jainam (Cambridge, MA), Baldwin; Geoff (Cambridge, MA), Venkatesh; Priyanka (New York, NY), Wright; Christopher (Somerville, MA), Kershaw; Thomas (Swampscott, MA)
Applicant:
Name City State Country Type

Apex Neuro Inc.

Cambridge

MA

US
Assignee: Apex Neuro Holdings, Inc. (Brooklyn, NY)
Appl. No.: D/693,185
Filed: May 31, 2019

Current U.S. Class: D24/200
Current International Class: 2803
Field of Search: ;D24/200,185-187,214,107

References Cited [Referenced By]

U.S. Patent Documents
6077237 June 2000 Campbell
D615209 May 2010 Minogue
8682452 March 2014 Minogue
8914123 December 2014 Rigaux
D752766 March 2016 Guarraia
D816227 April 2018 Geissen
10695568 June 2020 Covalin
10828461 November 2020 Cartledge
2008/0097549 April 2008 Colbaugh
2019/0232046 August 2019 Chu
2019/0232047 August 2019 Chu
2020/0338348 October 2020 Honeycutt
2021/0060330 March 2021 Chu
Primary Examiner: Laymon; Wan
Attorney, Agent or Firm: Hassid; Steve Partners Law Group Inc.

Description



FIG. 1 is a perspective view of a transcutaneous neuromodulation device according to our new design, where the device generally includes a headband component for engaging a wearer's head and connecting to two interface components generally aligned with the wearer's mastoid region.

FIG. 2 is a rear view thereof; and,

FIG. 3 is a front view thereof.

The features shown in broken lines in various figures are for illustrating portions of the transcutaneous neuromodulation device and form no part of the claimed design.

Omitted views of the device of our new design are clearly understood and fully disclosed in the perspective views shown in the figures.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed